Microbot Medical Inc.

NasdaqCM:MBOT Stock Report

Market Cap: US$12.7m

Microbot Medical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Microbot Medical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated17 Aug 2023

Recent future growth updates

Recent updates

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Sep 01
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Dec 28
Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical acquires Nitiloop, terms undisclosed

Oct 07

Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Sep 13
Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical confirms GLP trial on track to begin later this month

Sep 02

Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Apr 23
Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier

Jan 06

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

Dec 24
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Aug 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

May 12
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Jan 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Microbot Medical's study of surgical robotic system meets endpoints

Jan 14

Earnings and Revenue Growth Forecasts

NasdaqCM:MBOT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2024N/AN/AN/AN/A1
12/31/2023N/A-11-9-9N/A
9/30/2023N/A-11-9-9N/A
6/30/2023N/A-12-10-10N/A
3/31/2023N/A-13-12-12N/A
12/31/2022N/A-13-12-12N/A
9/30/2022N/A-14-12-12N/A
6/30/2022N/A-13-11-11N/A
3/31/2022N/A-12-10-10N/A
12/31/2021N/A-11-9-9N/A
9/30/2021N/A-10-8-8N/A
6/30/2021N/A-10-8-8N/A
3/31/2021N/A-9-7-7N/A
12/31/2020N/A-9-7-7N/A
9/30/2020N/A-8-8-7N/A
6/30/2020N/A-8-7-7N/A
3/31/2020N/A-7-6-6N/A
12/31/2019N/A-7-7-6N/A
9/30/2019N/A-8-6-6N/A
6/30/2019N/A-7-6-6N/A
3/31/2019N/A-8-7-7N/A
12/31/2018N/A-7-6-5N/A
9/30/2018N/A-7-5-5N/A
6/30/2018N/A-6-5-5N/A
3/31/2018N/A-8-5-5N/A
12/31/2017N/A-8-5-5N/A
9/30/2017N/A-14N/A-4N/A
6/30/2017N/A-14N/A-3N/A
3/31/2017N/A-11N/A-1N/A
12/31/2016N/A-10N/A-1N/A
9/30/2016N/A-2N/A-1N/A
6/30/2016N/A-1N/A-1N/A
3/31/2016N/A-1N/A-1N/A
12/31/2015N/A-1N/A-1N/A
12/31/2014N/A-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MBOT's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if MBOT's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if MBOT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MBOT's revenue is forecast to grow faster than the US market.

High Growth Revenue: MBOT is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MBOT's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.